Public land‑grant flagship of Arkansas’s university system
Measles cases in the U.S. have surged to 2,371 this year, the highest in years, prompting renewed calls for vaccination amid political and public health pressures. Outbreaks are intensifying in several states as officials warn that vaccination alone may not curb spread. Health Secretary Kennedy faces scrutiny over his vaccine stance while states push to bolster immunization programs.
Moderna has won FDA approval for its mRNA flu vaccine mFlusiva for adults 50–64 and accelerated approval for those 65 and older. The decision follows a contentious review earlier this year, a unanimous advisory panel recommendation in June and political disputes inside US health agencies over mRNA vaccines. Retail availability is expected in coming weeks.